Inozyme Pharma, Inc. - Common Stock, par value $0.0001 per share (INZY)

CUSIP: 45790W108

Q4 2020 13F Holders as of 31 Dec 2020

Type / Class
Equity / Common Stock, par value $0.0001 per share
Shares outstanding
64,967,756
Total 13F shares
18,360,151
Share change
+463,653
Total reported value
$378,973,000
Price per share
$20.64
Number of holders
53
Value change
+$7,774,419
Number of buys
29
Number of sells
17

Quarterly Holders Quick Answers

What is CUSIP 45790W108?
CUSIP 45790W108 identifies INZY - Inozyme Pharma, Inc. - Common Stock, par value $0.0001 per share in SEC institutional holdings data.

Need full ownership history?
Open the full security ownership history page.

Institutional Holders of Inozyme Pharma, Inc. - Common Stock, par value $0.0001 per share (INZY) as of Q4 2020

As of 31 Dec 2020, Inozyme Pharma, Inc. - Common Stock, par value $0.0001 per share (INZY) was held by 53 institutional shareholders that filed Form 13F with the SEC. Together, they reported ownership of 18,360,151 shares. The largest 10 holders included Novo Holdings A/S, NEA Management Company, LLC, Sofinnova Investments, Inc., RA CAPITAL MANAGEMENT, L.P., Pivotal bioVenture Partners Investment Advisor LLC, DEERFIELD MANAGEMENT COMPANY, L.P. (SERIES C), CHI Advisors LLC, ADAGE CAPITAL PARTNERS GP, L.L.C., Rock Springs Capital Management LP, and BlackRock Inc.. This page lists 53 institutional shareholders reporting positions in this security for the Q4 2020 filing period.
Investor Option Weight % Change % Value $ * Price Shares Share Change Activity Report Period
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.